Equilin

Equilin Impurities

Equilin impurities include process-related substances, degradation products, and structurally related analogs that may arise during synthesis, formulation, or storage. These impurities are monitored to ensure the safety, efficacy, and quality of this estrogenic steroid used in hormone replacement therapy. All materials are structurally confirmed and qualified under ICH guidelines for pharmaceutical analysis and toxicological evaluation.

Equilin EP Impurities

We offer pharmacopeial and non-pharmacopeial Equilin impurities that comply with European Pharmacopoeia (EP) specifications. These impurity standards are essential for method development, impurity profiling, and stability testing. Analytical techniques such as HPLC, LC-MS, and NMR are used for their identification and quantification. EP traceable standards are available upon request.

Equilin Related Compounds

Our catalog includes Equilin-related compounds that support forced degradation studies, impurity identification, and genotoxicity screening. These materials are structurally characterized and supported by comprehensive analytical documentation, ensuring suitability for regulatory submissions and quality control.

Equilin Impurity Reference Standards

Equilin impurity reference standards are supplied with validated analytical data including NMR, MS, and HPLC purity. These materials are used in pharmaceutical R&D, ANDA and DMF filings, method validation, and GMP-compliant quality control. EP/USP traceable entries are available upon request, and all products meet international regulatory expectations. Supplied materials are re-tested at regular intervals to ensure consistency.